Masimo Corporation (MASI)
After hours:
| Previous Close | 137.92 |
| Open | 142.14 |
| Bid | 137.78 x 100 |
| Ask | 138.08 x 200 |
| Day's Range | 137.40 - 143.50 |
| 52 Week Range | 75.22 - 198.00 |
| Volume | |
| Avg. Volume | 572,609 |
| Market Cap | 7.308B |
| Beta (5Y Monthly) | 0.98 |
| PE Ratio (TTM) | 92.07 |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | Nov 23, 2012 |
| 1y Target Est | N/A |
- Simply Wall St.
Is There An Opportunity With Masimo Corporation's (NASDAQ:MASI) 24% Undervaluation?
Key Insights Masimo's estimated fair value is US$181 based on 2 Stage Free Cash Flow to Equity Current share price of...
- Fortune
Another proxy battle unfolds in the health tech industry
Shareholder displeasure with a Masimo Corp. acquisition opened the door to an activist investor.
- Reuters
Apple asks US appeals court to reverse Apple Watch import ban
Apple urged a U.S. appeals court on Friday to overturn a U.S. trade tribunal's decision to ban imports of some Apple Watches in a patent dispute with medical-monitoring technology company Masimo. Apple told the U.S. Court of Appeals for the Federal Circuit that the U.S. International Trade Commission's decision was based on a "series of substantively defective patent rulings," and that Masimo failed to show it had invested in making competing U.S. products that would justify the order. Representatives for Apple and Masimo did not immediately respond to requests for comment on the filing.
